A suite of highly specific, proprietary bacterial drug targets in staphylococcus aureus, that can be used individually or as a group to develop small molecule or peptide drug leads with powerful anti-infectives properties. More
Compositions and methods for improving the growth characteristics of cells engineered to produce biologically active products such as antibodies or glycosylated proteins. More
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
Patented technology regarding a superior adjuvant with the active substance polysaccharide for oral/nasal vaccines against influenza and bird influenza, targeted to the aging population. More
These hybrid antibody molecules can be engineered with a variety of small synthetic molecules, and the combination of immunogenic properties results in compounds with powerful target destruction or imaging capabilities. More
The present invention utilizes the characteristic chemical property of hydrazide groups on one reactant to react with aldehyde groups or cyanate esters on the other reactant with an improved conjugate yield of at least sixty percent. More
All rights reserved. Terms and Conditions | Contact us
